SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-17-111882
Filing Date
2017-04-05
Accepted
2017-04-05 16:44:03
Documents
4
Period of Report
2017-04-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d369719d8k.htm 8-K 37158
2 EX-4.1 d369719dex41.htm EX-4.1 203535
3 EX-99.1 d369719dex991.htm EX-99.1 15089
4 GRAPHIC g369719g16g24.jpg GRAPHIC 3915
  Complete submission text file 0001193125-17-111882.txt   262676
Mailing Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4
Business Address FIFTH FLOOR, WATERLOO EXCHANGE WATERLOO ROAD DUBLIN L2 4 353-1-634-7800
Jazz Pharmaceuticals plc (Filer) CIK: 0001232524 (see all company filings)

IRS No.: 981032470 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33500 | Film No.: 17743083
SIC: 2834 Pharmaceutical Preparations